Intestinal microbiota and brain health

The intestinal microbiota refers to the collection of microorganisms living in the intestines, which support digestion and provide some protection to the colon. Recent research has suggested a connection between this microbiome and neurological conditions, including Alzheimer's disease.

New findings on Alzheimer's disease

A study published on September 3, 2026, in Nature Neuroscience reveals new insights into Alzheimer's and other neurodegenerative diseases, which are marked by the buildup of the tau protein in the brain as tangles. These tangles are linked to an immune response, though its exact role is still unclear.

Immune response starts outside the brain

The research, led by David Holtzman and Jason Ulrich, identifies an immune circuit that begins outside the brain. T lymphocytes, a type of white blood cell, are more numerous in the brains of people with Alzheimer's, especially CD8 T lymphocytes, known for attacking abnormal cells.

Lymph nodes as activation sites

The study suggests that damaged neurons release debris, which reaches the deep cervical lymph nodes in the neck. Dendritic cells in these nodes present these fragments to CD8 T lymphocytes, which then travel to the brain. However, the exact signal triggering this process is still unknown.

Blocking dendritic cells reduces brain damage

In genetically modified mice unable to produce certain dendritic cells, CD8 T lymphocytes were fewer and less active in the brain. This led to reduced inflammation, brain tissue loss, and better cognitive function, even though the amount of tau tangles remained unchanged.

Study limitations and relevance

The research was conducted on mice with a specific genetic model that reproduces tau-related degeneration but not the amyloid plaques found in Alzheimer's. This model is more relevant to certain tauopathies than to Alzheimer's as a whole.

Future research and potential treatments

Researchers are now investigating whether blocking dendritic cells in adult mice provides similar protection to blocking them from birth. They are also looking for the signal that guides T lymphocytes to the brain. The study's findings may lead to new treatments that avoid crossing the blood-brain barrier, using existing therapies and exploring nanobodies from camelids for potential brain-targeted interventions.